Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Disease Reports
Autologous blood transfusion
MeSH D001804 - autologous blood transfusion
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D001803:
Blood transfusion
0 Companies
0 Drugs
Success rate
D001804:
Â
Autologous blood transfusion
3 Companies
1 Drug
$
Success rate
Events Timeline
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
Pfizer
Epoetin
Â
RetacritÂ
Â
2007-12-18Â
$340 MÂ
Y2023Â
Roche
Epoetin
Â
NeoRecormonÂ
Â
1997-07-16Â
Â
Â
Stada Arzneimittel
Epoetin
Â
SilapoÂ
Â
2007-12-18Â
Â
Â
Clinical Trials
Historical Success Rate
Phase 1
0
%
0/0
Phase 2
100
%
4/4
Phase 3
67
%
4/6
Approved:
2
Overall Success rate:
0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Pfizer
Epoetin
,
Epoetin delta
Roche
Epoetin
,
Epoetin delta
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use